Medtronic Neuromodulation recalls A820 myPTM Software Application…
Medtronic Neuromodulation recalls A820 myPTM Software Application associated with Medtronic SynchroMe…
- Published
- 9 Apr 2025
- Units affected
- 4365 units
- Agency
- FDA
- Country
- United States
The hazard
Product complaints were received describing the A820 myPTM app taking longer than expected for patients to interact with their implantable pump.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.
- Check the model and lot or serial number on the device label.
- Speak to your doctor or the clinic that supplied the device before stopping use.
Product details
A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion System.
- Brand / company
- Medtronic Neuromodulation
- Codes / lots
- version v.2x, UDI/DI 00763000632793
- Distribution
- Worldwide distribution - US Nationwide and the countries of Austria, Belgium, Canary Islands, Czech Republic, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Puerto Rico, Spain, Sweden, Switzerland, United Kingdom.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 9 Apr 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.